NICE recommends capivasertib for advanced breast cancer Clinical trial results revealed that capivasertib, taken with fulvestrant, can provide advanced breast cancer patients with an additional four months before their cancer progresses.…
First UK joint asthma guidance: what does it mean for practice? In this episode of The PJ Pod, we explore the main changes and implications for practice brought about by the UK-wide joint asthma guideline.…
NICE approves first NHS treatment for advanced blood cancer Brentuximab combination therapy is a first-line treatment option for previously untreated stage 3 or 4 CD30-positive Hodgkin lymphoma that could benefit up to 800 people annually.…
BMI should be recorded annually for people with long-term conditions, says NICE The draft quality standard on overweight and obesity management also advises healthcare professionals to seek permission in a sensitive, non-judgemental way before discussing weight.…
NICE recommends first combination pill for long-term treatment of endometriosis Relugolix combination therapy is a second-line treatment option for endometriosis that is faster acting than injectable treatments and can be taken at home.…
HIV patients should switch to long-acting antiretroviral injectable treatments sooner, study concludes Researchers found that 98% of patients who were not virally suppressed at the start of the study had non-detectable viral loads after 11 months of long-acting antiretroviral injectable treatment.…
Alzheimer’s treatments donanemab and lecanemab still not recommended under latest NICE draft guidance NICE says that the cost of implementing donanemab and lecanemab across the NHS is “significantly higher” than considered acceptable for taxpayers’ money and NHS resources.…
NICE recommends once-weekly injection for severe blood clotting disorder Efanesoctocog alfa, a once-weekly treatment for patients with severe haemophilia A, removes the need for frequent dosing, owing to its effective bleeding control.…
First non-cannabis treatment for rare form of epilepsy made available on NHS Fenfluramine is a non-cannabis treatment for patients with Lennox-Gastaut syndrome who do not respond to existing treatments or clobazam owing to its side effects.…
NICE approves gene-editing sickle cell therapy for NHS in England Exagamglogene autotemcel, also known as exa-cel, is now recommended for NHS use, reversing previous draft guidance.…
